Update der S 3-Leitlinie Prophylaxe, Diagnostik und Therapie der Hepatitis-C-Virus(HCV)-Infektion, AWMF-Register-Nr.: 021/012 [Prophylaxis, diagnosis and therapy of hepatitis C virus (HCV) infection: the German guidelines on the management of HCV infection]


Autoria(s): Sarrazin C.; Berg T.; Ross R.S.; Schirmacher P.; Wedemeyer H.; Neumann U.; Schmidt H.H.; Spengler U.; Wirth S.; Kessler H.H.; Peck-Radosavljevic M.; Ferenci P.; Vogel W.; Moradpour D.; Heim M.; Cornberg M.; Protzer U.; Manns M.P.; Fleig W.E.; Dollinger M.M.; Zeuzem S.
Data(s)

2010

Identificador

http://serval.unil.ch/?id=serval:BIB_624C4D2B6384

isbn:1439-7803[electronic], 0044-2771[linking]

pmid:20119896

doi:10.1055/s-0028-1110008

isiid:000274302800007

Idioma(s)

de

Fonte

Zeitschrift für Gastroenterologie, vol. 48, no. 2, pp. 289-351

Palavras-Chave #Human-Immunodeficiency-Virus; Liver-Transplant Recipients; Sustained Virological Response; Interferon-Alpha Therapy; Injection-Drug Users; Quality-of-Life; To-Child Transmission; Ribavirin Combination Therapy; Randomized Controlled-Trial; Health-Care Workers
Tipo

info:eu-repo/semantics/review

article